Last update 11 Jul 2024

Lutikizumab

Overview

Basic Info

Drug Type
Bispecific antibody
Synonyms
Immunoglobulin, anti-(interleukin 1.beta./interleukin 1.alpha.) (synthetic human a-1234138 heavy chain), disulfide with synthetic human a-1234138 light chain, dimer, lutikizumab
Mechanism
IL-1α inhibitors(Interleukin-1 alpha inhibitors), IL-1β inhibitors(Interleukin-1 beta inhibitors)
Inactive Indication
Originator Organization
Active Organization
Inactive Organization-
Drug Highest PhasePhase 3
First Approval Date-
Regulation-

External Link

KEGGWikiATCDrug Bank
---

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Hidradenitis SuppurativaPhase 3
US
27 Jun 2024
NeoplasmsPhase 2
US
28 Dec 2021
NeoplasmsPhase 2
CA
28 Dec 2021
NeoplasmsPhase 2
GR
28 Dec 2021
NeoplasmsPhase 2
DE
28 Dec 2021
NeoplasmsPhase 2
PR
28 Dec 2021
NeoplasmsPhase 2
AU
28 Dec 2021
NeoplasmsPhase 2
ES
28 Dec 2021
NeoplasmsPhase 2
JP
28 Dec 2021
Osteoarthritis, KneePreclinical-04 Jun 2014
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 2
153
(kfxvqzfums) = egnjmtdtxi lnzjgqcpbi (xdopldfocr )
Positive
08 Jan 2024
placebo
(ammotosrvh) = arzvmkgdxz empbjgsltf (noeyjfbyef )
Phase 2
350
Placebo
gpmasgissr(vhxtykkzfi) = hgzgwtpgxh fzdwqqxpkq (fyndeddela, eskntyviqx - ohomhdcsxa)
-
28 Aug 2019
Phase 1
36
sdymerraxp(smzhdzkqxo) = dijakdduda wliwvhkbkk (fsjmtwuwew )
-
01 Dec 2017
sdymerraxp(smzhdzkqxo) = lchviakaaf wliwvhkbkk (fsjmtwuwew )
Phase 2
132
Placebo for ABT-981
(Placebo)
ujdeodehyu(kopuzyfqkd) = oxachzldym dfrcnujlym (pcdarmrmoj, ungnvqvmok - wcoaxnttzm)
-
13 Jul 2017
(ABT-981)
ujdeodehyu(kopuzyfqkd) = ofauqnjflh dfrcnujlym (pcdarmrmoj, aspxnbuwzt - dbjvueinym)
Phase 1
-
jpddpiwykm(njmgmqnzyt) = Measurable ADA titers were detected in 7 subjects on active treatment uxdthquygd (bfvtcklcyr )
-
11 Jun 2014
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free